CA2036844A1 - Aerosol permettant une liberation reglee de microspheres de procaterol - Google Patents

Aerosol permettant une liberation reglee de microspheres de procaterol

Info

Publication number
CA2036844A1
CA2036844A1 CA 2036844 CA2036844A CA2036844A1 CA 2036844 A1 CA2036844 A1 CA 2036844A1 CA 2036844 CA2036844 CA 2036844 CA 2036844 A CA2036844 A CA 2036844A CA 2036844 A1 CA2036844 A1 CA 2036844A1
Authority
CA
Canada
Prior art keywords
microspheres
formulation
albumin
propellant
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2036844
Other languages
English (en)
Inventor
Hua-Pin Huang
Surendra C. Mehta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of CA2036844A1 publication Critical patent/CA2036844A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
CA 2036844 1990-02-22 1991-02-21 Aerosol permettant une liberation reglee de microspheres de procaterol Abandoned CA2036844A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48501390A 1990-02-22 1990-02-22
US485,013 1990-02-22

Publications (1)

Publication Number Publication Date
CA2036844A1 true CA2036844A1 (fr) 1991-08-23

Family

ID=23926589

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2036844 Abandoned CA2036844A1 (fr) 1990-02-22 1991-02-21 Aerosol permettant une liberation reglee de microspheres de procaterol

Country Status (1)

Country Link
CA (1) CA2036844A1 (fr)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US8709484B2 (en) 2000-05-10 2014-04-29 Novartis Ag Phospholipid-based powders for drug delivery
US8715623B2 (en) 2001-12-19 2014-05-06 Novartis Ag Pulmonary delivery of aminoglycoside
US8877162B2 (en) 2000-05-10 2014-11-04 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery
US9554993B2 (en) 1997-09-29 2017-01-31 Novartis Ag Pulmonary delivery particles comprising an active agent

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8080263B2 (en) 1997-09-29 2011-12-20 Novartis Ag Dispersion for pulmonary delivery of a bioactive agent
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6638495B2 (en) 1997-09-29 2003-10-28 Nektar Therapeutics Stabilized preparation for use in metered dose inhalers
US7205343B2 (en) 1997-09-29 2007-04-17 Dellamary Luis A Stabilized bioactive preparations and method of use
US7393544B2 (en) 1997-09-29 2008-07-01 Nektar Therapeutics Dispersion for pulmonary delivery of a bioactive agent
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US9554993B2 (en) 1997-09-29 2017-01-31 Novartis Ag Pulmonary delivery particles comprising an active agent
US8877162B2 (en) 2000-05-10 2014-11-04 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery
US8709484B2 (en) 2000-05-10 2014-04-29 Novartis Ag Phospholipid-based powders for drug delivery
US9439862B2 (en) 2000-05-10 2016-09-13 Novartis Ag Phospholipid-based powders for drug delivery
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US8715623B2 (en) 2001-12-19 2014-05-06 Novartis Ag Pulmonary delivery of aminoglycoside
US9421166B2 (en) 2001-12-19 2016-08-23 Novartis Ag Pulmonary delivery of aminoglycoside

Similar Documents

Publication Publication Date Title
AU603139B2 (en) A new system for administration of liposomes to mammals
KR910004580B1 (ko) 의약용 소입자 에어로졸 리포좀 및 의약용 리포좀-약제 조합물
RU2162689C2 (ru) Пролипосомные порошки для ингаляции
US5891469A (en) Solid Coprecipitates for enhanced bioavailability of lipophilic substances
AU730216B2 (en) Solid coprecipitates for enhanced bioavailability of lipophilic substances
Cook et al. Novel sustained release microspheres for pulmonary drug delivery
AU756669B2 (en) Compositions comprising cannabinoids
AU612591B2 (en) Pharmaceutical formulations comprising microcapsules
US4610868A (en) Lipid matrix carriers for use in drug delivery systems
EP0167825B1 (fr) Nanobilles lipidiques comme véhicule pour médicaments destinés à l'administration orale
CA2036844A1 (fr) Aerosol permettant une liberation reglee de microspheres de procaterol
KR20030011816A (ko) 약학적 조제약 및 그 제조 방법
JP2002510311A (ja) トコフェロールにより安定化された吸引用プロリポソーム粉末
WO1987005803A1 (fr) COMPOSITIONS DE LIPOSOMES ET SUBSTANCES ACTIVES beta2-RECEPTRICES
KR101180181B1 (ko) 나노 입자 및 그의 제조 방법
JPH0776180B2 (ja) 吸入アレルゲンを含有するアレルギー治療用リポソーム
Sirisha et al. World Journal of Pharmaceutical Sciences
JPH11222424A (ja) 医療用のリポソームおよび薬物含有リポソームのエアゾールの小粒子
JP3202704B2 (ja) 医療用のリポソームおよび薬物含有リポソームのエアゾールの小粒子
Jin Microsphere formulation strategies, cell uptake studies, and pharmacokinetics in rats
Kamble et al. Zileuton-Liposomal Dry Powder for Inhalation: In-Vitro and In-Vivo Characterization
IL119176A (en) Soluble coprecipitates for enhanced oral bioavailability of lipophilic substances

Legal Events

Date Code Title Description
FZDE Dead